Blanchard Valley Health System, or, is a non-profit, integrated regional health system based in Findlay, a city in Ohio. Governed by a community board of trustees representing large and small business, education, law, medicine, and finance, BVHS oversees all operations of its member organizations.

There are 150 beds in Blanchard Valley Hospital.

During the past decade, Blanchard Valley Hospital conducted 108 clinical trials. In the 10-year time frame, 108 clinical trials started and 111 clinical trials were completed, i.e. on average, 102.8% percent of trials that started reached the finish line to date. In the past 5 years, 29 clinical trials started and 52 clinical trials were completed. i.e. 179.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blanchard Valley Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 134 trials, followed by "SWOG Cancer Research Network" with 33 trials sponsored, "Alliance for Clinical Trials in Oncology" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 20 trials sponsored and "NRG Oncology" with 20 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blanchard Valley Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 21 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "Cancer and Leukemia Group B" with 5 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Blanchard Valley Hospital" are "Recurrent Breast Carcinoma" (12 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Breast Cancer AJCC v6 and v7" (9 trials), "Stage IV Lung Cancer AJCC v8" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Blanchard Valley Hospital" in a lesser frequency.

Most popular intervention types in "Blanchard Valley Hospital" are "Drug" (206 trials), "Other" (148 trials), "Biological" (104 trials), "Procedure" (50 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (90 trials), "Quality-of-Life Assessment" (54 trials), "Paclitaxel" (34 trials), "Carboplatin" (33 trials) and "Questionnaire Administration" (26 trials). Other intervention names were less common.

The vast majority of trials in "Blanchard Valley Hospital" are 194 trials for "All" genders, 34 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Blanchard Valley Hospital". undefined are not yet recruiting, 50 are recruiting, 104 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 61 completed trials in Blanchard Valley Hospital, 3 suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in Blanchard Valley Hospital, 9 "Phase 1" clinical trials were conducted, 122 "Phase 2" clinical trials and 115 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".

Blanchard Valley Hospital has several departments that took part in Clinical trials: "Armes Family Cancer Center" - 143 trials, "Orion Cancer Care" - 135 trials